Estimated Cost of Developing a Therapeutic Complex Medical Device in the US

Risk of Recall Among Medical Devices Undergoing US Food and Drug Administration 510(k) Clearance and Premarket Approval, 2008-2017

(2021) Jonathan R. Dubin et al.   JAMA Network Open

Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018

(2020) Olivier J. Wouters et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Key cost drivers of pharmaceutical clinical trials in the United States

(2016) Aylin Sertkaya et al.   Clinical Trials

Innovation in the pharmaceutical industry: New estimates of R&D costs

(2016) Joseph A. DiMasi et al.   JOURNAL OF HEALTH ECONOMICS

Characteristics of Clinical Studies Conducted Over the Total Product Life Cycle of High-Risk Therapeutic Medical Devices Receiving FDA Premarket Approval in 2010 and 2011

(2015) Vinay K. Rathi et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Characteristics of Pivotal Trials and FDA Review of Innovative Devices

(2015) Joshua P. Rising et al.   PLoS One